Zepbound, Obstructive Sleep Apnea
The US Food and Drug Administration has approved the first ever prescribed medicine for Obstructive Sleep Apnea. Read on to ...
Sleep apnea affects millions globally, often lurking undetected until it begins impacting overall health. While high blood ...
July 23, 2024 — Nearly 40 million adults in the U.S. have sleep apnea, and more than 30 million of them use a continuous positive airway pressure (CPAP) machine while sleeping. However ...
The U.S. Food and Drug Administration (FDA) has approved Zepbound, a prescription weight-loss medication, as the first drug ...
There are many consequences of untreated OSA, and all of these are more likely with more-severe obstruction. Because people with OSA don't sleep well, they are at a higher risk for motor vehicle ...
Sleep apnea affects 25 million Americans and 100 million individuals worldwide. Prior to the approval of Zepbound, those affected have mainly been offered a CPAP machine for treatment, often ...
“Today’s approval marks the first drug treatment option for certain patients with obstructive sleep apnea,” said Sally Seymour, M.D., director of the Division of Pulmonology, Allergy, and Critical ...